Amrutanjan Health Care — 360° view

Amrutanjan Health Care, a company in the Pharmaceuticals industry, reported revenue of ₹135 crore and net profit of ₹17 crore for the September 2026 quarter.

Amrutanjan Health Care (NSE: AMRUTANJAN) closed at ₹512.65 on 20 Nov 2026, down 26.9% over the past year. Its market capitalisation is ₹1,482 crore and it trades at 22.6 times earnings.

Share price
₹512.65 (20 Nov 2026)
Market cap
₹1,482 Cr (20 Nov 2026)
P/E
22.62 (20 Nov 2026)
Revenue
₹135 Cr (September 2026 quarter)
Net profit
₹17 Cr (September 2026 quarter)
ROCE
24.8% (FY26)
ROE
18.4% (FY26)
Book value
₹133 (FY26)
Dividend yield
0.96% (last 12 months to 20 Nov 2026)
52-week high / low
₹705.45 / ₹476.50 (20 Nov 2026)
1-year return
-26.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: AMRUTANJAN

AHCL has been manufacturing ayurvedic balm for pain management since 1893, and is currently managed by the third-generation of promoters. The company is more than 120 years old and is into OTC products in the segments of pain management, women's hygiene, and packaged fruit juice drink.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.